Details of the Drug

General Information of Drug (ID: DMCVCZ6)

Drug Name
LX-6171
Synonyms CNS therapeutics, Lexicon; LG617 program, Lexicon
Indication
Disease Entry ICD 11 Status REF
Neurological disorder 6B60 Phase 2 [1]
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C22H20ClN3O
Canonical SMILES
C1CN(CCC1C(=O)C2=CC=C(C=C2)C3=CC(=CC=C3)Cl)C4=NC=CC=N4
InChI
1S/C22H20ClN3O/c23-20-4-1-3-19(15-20)16-5-7-17(8-6-16)21(27)18-9-13-26(14-10-18)22-24-11-2-12-25-22/h1-8,11-12,15,18H,9-10,13-14H2
InChIKey
VHTIWIZIPOXSNP-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
15950717
CAS Number
914808-66-5
UNII
61CSC3D89K
DrugBank ID
DB05180
TTD ID
D0B8TK

References

1 ClinicalTrials.gov (NCT00691808) Study of LX6171 in Elderly Volunteers With Age Associated Memory Impairment. U.S. National Institutes of Health.